Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Urinary PSA could be an early marker for enlarged prostate.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The desmopressin stimulation test helped identify an adrenal cause for a patient's Cushing's syndrome.

Correcting vitamin D and progesterone deficiencies can significantly improve hair loss, acne, and BPH symptoms.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Hair loss linked to prostate enlargement; stress and family history important factors.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Metyrapone can effectively treat Cushing's Disease even if the mass causing it is not found.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Finasteride improves urinary function in men for 2 years.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.